Hambrecht & Quist Capital Management as of Sept. 30, 2011
Portfolio Holdings for Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management holds 72 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 5.3 | $23M | 585k | 38.80 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.2 | $23M | 505k | 44.54 | |
| Pharmasset | 4.9 | $21M | 256k | 82.37 | |
| Teva Pharmaceutical Industries (TEVA) | 3.5 | $15M | 405k | 37.22 | |
| Celgene Corporation | 3.2 | $14M | 223k | 61.92 | |
| Alexion Pharmaceuticals | 3.2 | $14M | 211k | 64.06 | |
| Gen-Probe Incorporated | 3.0 | $13M | 228k | 57.25 | |
| Akorn | 3.0 | $13M | 1.6M | 7.81 | |
| Perrigo Company | 3.0 | $13M | 130k | 97.11 | |
| Biogen Idec (BIIB) | 2.9 | $12M | 133k | 93.15 | |
| Aetna | 2.6 | $11M | 308k | 36.35 | |
| Mylan | 2.6 | $11M | 657k | 17.00 | |
| Cubist Pharmaceuticals | 2.4 | $10M | 289k | 35.32 | |
| Human Genome Sciences | 2.4 | $10M | 799k | 12.69 | |
| Incyte Corporation (INCY) | 2.1 | $9.2M | 655k | 13.97 | |
| PerkinElmer (RVTY) | 2.1 | $9.1M | 476k | 19.21 | |
| Shire | 2.1 | $9.0M | 96k | 93.93 | |
| Amgen (AMGN) | 2.1 | $8.8M | 161k | 54.95 | |
| Baxter International (BAX) | 2.0 | $8.8M | 156k | 56.14 | |
| United Therapeutics Corporation (UTHR) | 1.9 | $8.2M | 219k | 37.49 | |
| CVS Caremark Corporation (CVS) | 1.9 | $8.1M | 242k | 33.58 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.9 | $7.9M | 85k | 93.35 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $7.3M | 1.2M | 5.98 | |
| Allergan | 1.6 | $7.1M | 86k | 82.38 | |
| Warner Chilcott Plc - | 1.6 | $6.9M | 481k | 14.30 | |
| Medco Health Solutions | 1.6 | $6.8M | 145k | 46.89 | |
| Express Scripts | 1.4 | $6.1M | 164k | 37.07 | |
| Elan Corporation | 1.4 | $6.1M | 578k | 10.53 | |
| Cerner Corporation | 1.3 | $5.5M | 81k | 68.52 | |
| Amarin Corporation | 1.3 | $5.5M | 601k | 9.20 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $5.4M | 106k | 50.64 | |
| Intellipharmaceuticsintl Inc C | 1.2 | $5.2M | 1.6M | 3.35 | |
| Inhibitex | 1.2 | $5.1M | 2.1M | 2.46 | |
| UnitedHealth (UNH) | 1.2 | $5.0M | 108k | 46.12 | |
| IDEXX Laboratories (IDXX) | 1.1 | $4.9M | 71k | 68.97 | |
| Zimmer Holdings (ZBH) | 1.1 | $4.8M | 89k | 53.51 | |
| Merck & Co (MRK) | 1.1 | $4.5M | 137k | 32.71 | |
| Quest Diagnostics Incorporated (DGX) | 1.0 | $4.4M | 90k | 49.36 | |
| McKesson Corporation (MCK) | 1.0 | $4.1M | 57k | 72.70 | |
| Kinetic Concepts | 1.0 | $4.2M | 63k | 65.88 | |
| PAREXEL International Corporation | 0.9 | $3.9M | 208k | 18.93 | |
| Pharmaceutical Product Development | 0.9 | $3.8M | 148k | 25.66 | |
| Natus Medical | 0.9 | $3.8M | 402k | 9.51 | |
| Nektar Therapeutics | 0.9 | $3.7M | 759k | 4.85 | |
| Edwards Lifesciences (EW) | 0.8 | $3.3M | 47k | 71.27 | |
| Dendreon Corporation | 0.8 | $3.3M | 368k | 9.00 | |
| Jazz Pharmaceuticals | 0.6 | $2.7M | 66k | 41.52 | |
| Auxilium Pharmaceuticals | 0.6 | $2.6M | 175k | 14.99 | |
| Santarus | 0.6 | $2.4M | 876k | 2.79 | |
| Onyx Pharmaceuticals | 0.5 | $2.0M | 67k | 30.01 | |
| Boston Scientific Corporation (BSX) | 0.5 | $1.9M | 326k | 5.91 | |
| Keryx Biopharmaceuticals | 0.4 | $1.8M | 615k | 3.00 | |
| Addus Homecare Corp (ADUS) | 0.4 | $1.8M | 432k | 4.09 | |
| Watson Pharmaceuticals | 0.4 | $1.7M | 25k | 68.24 | |
| Acorda Therapeutics | 0.4 | $1.7M | 84k | 19.96 | |
| Affymax (AFFY) | 0.4 | $1.6M | 352k | 4.48 | |
| NPS Pharmaceuticals | 0.4 | $1.5M | 234k | 6.51 | |
| Zogenix | 0.3 | $1.5M | 800k | 1.83 | |
| Adolor Corporation (ADLR) | 0.3 | $1.4M | 822k | 1.72 | |
| LifePoint Hospitals | 0.3 | $1.3M | 36k | 36.63 | |
| Curis | 0.3 | $1.3M | 410k | 3.16 | |
| Hologic (HOLX) | 0.3 | $1.2M | 80k | 15.21 | |
| Hca Holdings (HCA) | 0.3 | $1.2M | 60k | 20.17 | |
| Cornerstone Therapeutics | 0.3 | $1.1M | 174k | 6.40 | |
| Health Management Associates | 0.2 | $953k | 138k | 6.92 | |
| Community Health Systems (CYH) | 0.2 | $938k | 56k | 16.65 | |
| Palomar Medical Technologies | 0.2 | $887k | 113k | 7.88 | |
| OncoGenex Pharmaceuticals | 0.2 | $912k | 93k | 9.80 | |
| Corcept Therapeutics Incorporated (CORT) | 0.2 | $775k | 250k | 3.10 | |
| XenoPort | 0.1 | $333k | 56k | 5.90 | |
| Telik (TELK) | 0.1 | $246k | 821k | 0.30 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $110k | 104k | 1.06 |